Dr. Gaudiani and Dr. Bernstein founded Marin Endocrine Care & Research in 1988. We are committed to patient care that goes beyond the standard diagnosis and prescription. We strive to create a plan of action that provides accurate diagnosis and ensures optimal and diverse management opportunities. We focus on individualized assessment, treatment, and support in a resourceful and motivating environment. Endocrine problems change over time, and so must our treatments.
As your physicians, we to hope to help patients to achieve healthy and fulfilling lives and we also work to achieve this in our own daily lives. We value professional duties and ongoing education, varied community involvement, as well as commitment to family, staff, and personal health habits of exercise and wellness. Over the years we continue to find our patients an inspiration and admire their courage and generosity, especially as many commit to furthering medical knowledge by participating in clinical trials.
Linda M. Gaudiani, MD, FACP, FACE, graduated from Bryn Mawr College with honors, Boston University School of Medicine with honors, and completed her internship in internal medicine at Boston City Hospital. She was awarded an NIH Fellowship in Nutrition at Berkeley, California, and then completed her Internal Medical residency at Stanford University Medical Center.
She then started her family and went on to accept and complete her fellowship and board certifications in Internal Medicine, Endocrinology and Metabolism at UCSF Medical Center. She was the recipient of the Dorothy Frank Diabetes Fellowship in recognition of her special interest in Diabetes. She was appointed to UCSF clinical faculty in 1985, and is currently an Assistant Clinical Professor of Medicine. Dr. Gaudiani was elected to receive a Golden Cane Award for best clinical volunteer faculty in 2008.
She has been in full time medical practice in Marin since 1985, establishing her partnership with Dr. Bernstein in 1988. She has been an active staff member of Marin General Hospital (MGH) for over 30 years, where she initiated and now serves as Medical Director of the Keys to Control Diabetes Inpatient Care Program. She is also founder and Medical Director of the new Braden Diabetes Center, also at MGH. She has served on the board and also as president of the Marin Chapter of the American Diabetes Association in past years. She has also recently co-authored a chapter in the ADA sponsored book, “Managing Diabetes and Hyperglycemia in the Hospital Setting”.
Dr. Gaudiani has been a frequent lecturer, hospital consultant, and was also elected Fellow of the American College of Physicians (FACP) and the American College of Clinical Endocrinologists (FACE). She has developed MECR’s research as primary investigator on numerous clinical trials in diabetes, osteoporosis, hypertension and obesity pharmaceutical development.
Dr. Gaudiani: “I am fortunate to be involved in the exciting forefront of endocrine care through my work in clinical research, and am grateful to the many patients who have helped make new treatment options the reality of the future. This is the horizon of clinical medicine until basic researchers unravel the cures for these conditions. For me, a sense of purpose each day provides happiness and fulfillment.”
Mickie Cheng, MD. A native of the Chicago area, Dr. Cheng attended Princeton University prior to pursuing her MD and PhD degrees at the University of Texas Southwestern Medical Center in Dallas, Texas. Following her residency in Internal Medicine at UT Southwestern, she completed her fellowship training at UCSF in endocrinology in 2008 and has held a faculty affiliation in the UCSF Diabetes center since that time. In this role, she has been active in clinical care through her work in the UCSF Diabetes clinic as well as in research efforts in collaboration with investigators such as Dr. Matthias Hebrok and Dr. Mark Anderson.
Looking to broaden her experience beyond the academic sphere as well as devote more effort to patient care, Dr. Cheng transitioned from academic practice to community-based practice in 2014. Drawn by the tradition of excellence in patient care and clinical research, she joined Marin Endocrine Care and Research in 2016, where she sees patients with a diverse range of general endocrine conditions as well as a large population of patients with diabetes. She enjoys a team-based approach to endocrine care and supports the vision of a comprehensive, longitudinal and dynamic approach to diabetes management. In addition to clinical care, Dr. Cheng continues to spend a small portion of her time involved in some translational research efforts in the genetics of autoimmune disease and Type 1 diabetes. As such, she has a special clinical interest in autoimmune endocrine disorders as well as female endocrine disorders such as PCOS and premature ovarian insufficiency.
Alexander V. Uihlein, MD studied medicine at the Northwestern University Feinberg School of Medicine, graduating with a MD in 2007. He went on to complete a residency in internal medicine at Northwestern and the University of Massachusetts. His fellowship training in endocrinology, diabetes, and metabolism was completed at the Massachusetts General Hospital in Boston. There he participated in investigator-initiated clinical trials studying new treatment paradigms for male osteoporosis and postmenopausal osteoporosis.
Dr. Uihlein and his family then started their journey westward, moving to Chicago in 2013. He practiced general endocrinology at Northwestern Medical Group from 2013 to 2016 and has especially enjoyed the opportunity to teach medical students in their longitudinal clinical experience.
He is excited to be a part of the Marin community and continue the tradition of excellence at Marin Endocrine Care and Research.